XML 55 R42.htm IDEA: XBRL DOCUMENT
v3.24.3

STOCKHOLDERS DEFICIENCY (Details Narrative) - USD ($) |  | 1 Months Ended | 3 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | ---
Apr. 12, 2023 | Jun. 20, 2024 | Feb. 29, 2024 | Oct. 31, 2023 | Oct. 20, 2023 | Sep. 30, 2024 | Sep. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2021 | Jan. 31, 2024
Stock-based compensation to stock options |  |  |  |  |  | $ 177,734 | $ 205,317 |  |  |  |  |
Unvested performance-based stock options granted |  |  |  |  |  | 418,945 | 88,911 |  |  |  |  |
Number of shares outstanding granted |  |  |  |  |  |  |  | 264,945 | 238,838 | 60,566 | 95,167 |
Stock-based compensation related to restricted stock units |  |  |  |  |  | $ 171,289 | $ 185,019 |  |  |  |  |
Number of outstanding shares of restricted stock units |  |  |  |  |  | 279,700 |  |  |  |  |  |
Unvested performance-based stock options granted estricted stock units |  |  |  |  |  | 274,549 | 59,842 |  |  |  |  |
Restricted stock units number of shares outstanding granted |  |  |  |  |  |  |  | 184,443 | 152,432 | 40,707 | 22,343 |
Withholding taxes related to restricted stock units, shares |  |  |  |  |  | 54,691 |  |  |  |  |  |
Fees and expenses |  |  |  | $ 9,109,117 | $ 4,573,948 | $ 9,224,056 |  |  |  |  |  |
Gross proceeds |  |  |  |  |  | 10,000,006 |  |  |  |  |  |
Exercise price per share |  |  |  |  | $ 2.12 |  |  |  |  |  |  | $ 5.46
Exercise price |  |  |  |  | $ 0.0001 |  |  |  |  |  |  |
Description of securities purchase agreement | The 2023 Equity Distribution Agreement and related prospectus is limited to sales of up to an aggregate maximum $50.0 million of shares of the Company’s common stock. The Company pays Canaccord 3.0% of the gross proceeds as a commission |  | an aggregate of 1,831,503 shares of common stock of the Company. Pursuant to the January 2024 Purchase Agreement, the Company issued to the investors in the January 2024 RD Offering unregistered warrants (the “January 2024 Private Warrants”) to purchase up to 1,831,503 shares of the Company’s common stock (the “January 2024 Private Warrant Shares”) in a concurrent private placement (the “Private Offering” and together with the January 2024 RD Offering, the “January 2024 Offering”). The shares of common stock and accompanying January 2024 Private Warrants were offered at a combined offering price of $5.46 |  | ) 1,325,000 shares of common stock (the “October 2023 Shares”), of the Company and (ii) pre-funded warrants (the “October 2023 Pre-Funded Warrants”) to purchase up to 1,033,491 shares of the Company’s common stock (the “October 2023 Pre-Funded Warrant Shares”). Pursuant to the October 2023 Purchase Agreement the Company also issued unregistered warrants (the “October 2023 Private Warrants”) to purchase up to 2,358,491 shares of the Company’s common stock (the “October 2023 Private Warrant Shares”) in a concurrent private placement (the “October 2023 Private Offering” and together with the October 2023 RD Offering, the “October 2023 Offering”). The October 2023 Shares and accompanying October 2023 Private Warrants were offered at a combined offering price of $2.12. The October 2023 Pre-Funded Warrants and accompanying October 2023 Private Warrants were offered at a combined offering price of $2.1199. The October 2023 Offering closed on October 24, 2023 |  |  |  |  |  |  |
Distributable value of dividend |  |  |  |  |  | $ 100 |  |  |  |  |  |
Stock Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  | $ 1.88 |  |  |  |  |  |  |  |  |  |
Purchase of warrant of common stock series A |  | 4,849,915 |  |  |  |  |  |  |  |  |  |
Description of existing holder purchase of warrants |  | (i) lower the exercise price to $1.88 per share for the 3,233,277 Existing Warrants being exercised pursuant to the Inducement Letter and (ii) issue to the Exercising Holder an aggregate of 4,849,915 warrants to purchase shares of common stock, comprised of Series A common stock purchase warrants to purchase 2,727,273 shares of common stock (the “June 2024 Series A Warrants”) and Series B common stock purchase warrants to purchase 2,122,642 (of which 1,624,201 shares of common stock are subject to stockholder approval) shares of common stock (the “June 2024 Series B Warrants” and together with the June 2024 Series A Warrants, the “June 2024 Inducement Warrants”). The Company received aggregate gross proceeds of $6,078,561 from the exercise of the Existing Warrants by the Exercising Holder (the “Warrant Inducement”) |  |  |  |  |  |  |  |  |  |
Exercising holder released shares |  |  |  |  |  | 1,443,277 |  |  |  |  |  |
Warrants to purchase |  | 3,233,277 |  |  |  |  |  |  |  |  |  |
Gross proceeds from exercise of Existing Warrants |  | $ 6,078,561 |  |  |  |  |  |  |  |  |  |
2024 Placement Agent Warrants |  |  |  |  |  |  |  |  |  |  |  |
Shares of Common Stock |  |  |  |  |  | 91,575 |  |  |  |  |  |
Exercise price |  |  |  |  |  | $ 6.825 |  |  |  |  |  |
Convertible Series A Preferred Stocks [Member] |  |  |  |  |  |  |  |  |  |  |  |
Convertible preferred stock were outstanding |  |  |  |  |  | 4,030 |  |  |  |  |  |
Aggregate value |  |  |  |  |  | $ 403,000 |  |  |  |  |  |
Conversion price |  |  |  |  |  | $ 75.45 |  |  |  |  |  |
Convertible shares |  |  |  |  |  | $ 1.33 |  |  |  |  |  |
Distributable value of dividend |  |  |  |  |  | $ 100 |  |  |  |  |  |
Distributable value of dividend additional |  |  |  |  |  | 100 |  |  |  |  |  |
2023 Equity Distribution Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |
Purchase of warrant shares |  |  |  |  |  | $ 1,033,491 |  |  |  |  |  |

X
- References No definition available. + Details
Name: | ptn_AggregateValue
Namespace Prefix: | ptn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_CashAvailableForDistributionsAdditional
Namespace Prefix: | ptn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | ptn_DescriptionOfExistingHolderPurchaseOfWarrants
Namespace Prefix: | ptn_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_DescriptionOfSecuritiesPurchaseAgreement
Namespace Prefix: | ptn_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_ExercisingHolderReleasedShares
Namespace Prefix: | ptn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_GrossProceeds
Namespace Prefix: | ptn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_NumberOfOutstandingSharesOfRestrictedStockUnits
Namespace Prefix: | ptn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | ptn_PurchaseOfWarrantOfCommonStockSeriesA
Namespace Prefix: | ptn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_PurchaseOfWarrantShares
Namespace Prefix: | ptn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedRSU
Namespace Prefix: | ptn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_SharesOfCommonStock
Namespace Prefix: | ptn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_StockBasedCompensationToStockOptions
Namespace Prefix: | ptn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_StockIssuedDuringPeriodValueRestrictedStockUnitshares
Namespace Prefix: | ptn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_StockIssuedDuringPeriodValueShareBasedCompensationToRestrictedStockUnits
Namespace Prefix: | ptn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_UnvestedPerformanceBasedStockOptionsGranted
Namespace Prefix: | ptn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_UnvestedPerformanceBasedStockOptionsGrantedEstrictedStockUnits
Namespace Prefix: | ptn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ptn_WarrantsToPurchaseShares
Namespace Prefix: | ptn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of cash eligible for distribution to members or limited partners of limited liability company (LLC) or limited partnership (LP), subject to reserves to be maintained as defined in operating or partnership agreement, or in a credit facility agreement. + References No definition available. + Details
Name: | us-gaap_CashAvailableForDistributions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total costs of sales and operating expenses for the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_CostsAndExpenses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Per share excess of preference in liquidation over convertible debt instrument's if-converted par or stated value of share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B + Details
Name: | us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Per share conversion price of preferred stock. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 + Details
Name: | us-gaap_PreferredStockConvertibleConversionPrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(16)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 + Details
Name: | us-gaap_PreferredStockSharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromWarrantExercises
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Net number of non-option equity instruments granted to participants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(01) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ptn_StockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=ptn_TwoThousandTwentyFourPlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=ptn_ConvertibleSeriesAPreferredStocksMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ptn_TwentyTwentyThreeEquityDistributionAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |